Volunteer Week 2025
Posted on: Tuesday 3 June 2025
Author: FPM
FPM is delighted to be celebrating Volunteer Week! This is a fantastic opportunity for us to extend our sincere thanks to all our volunteers, and to recognise the invaluable contributions they make to help FPM thrive.
As a charity, we really do appreciate the passion and commitment of our volunteers in supporting us in our mission to advance the science and practice of pharmaceutical medicine for the benefit of the public.
Whether serving on committees, sharing expertise at our events, contributing to consultations and expert group blogs, or offering time and knowledge in other ways, we are truly grateful for everything they do!
'Why do you volunteer with FPM?'
Ms Trishna Bharadia MFPM(Hon)
Volunteering for FPM is a way for me to have an impact on how the future of pharmaceutical medicine evolves, especially in the area of patient engagement. It’s enabled me to expand my professional network, participate in some fantastic events and increase my knowledge of the industry. I get just as much out of volunteering for FPM as I give!
Dr Birge Berns FFPM
Volunteering for FPM opens up so many opportunities and gives me a chance to utilise my extensive drug development experience and skills to mentor younger colleagues and support the advancement of our specialty to the benefit of our patients. As current chair of the Policy and Communication Group, I coordinate external communication from FPM and activities across our expert groups, which gives me good insight into cutting edge developments in a range of areas, provides new challenges, builds my professional network and friendships and is great fun!
Dr Laura Campbell FFPM
I value being part of a committed community of professionals working together toward shared goals. Together we uphold and promote high ethical standards, patient safety, and responsible drug development.
Dr Liz Clark FFPM
I volunteer for FPM because I wish to contribute to good practice in pharmaceutical medicine and related disciplines, particularly collaborative working with patients and patient communities to develop medicines and health technologies, both in development and day-to-day use.
Dr Daniela Dastros-Pitei MFPM(Dis)
The reasons for volunteering at FPM are two-fold. One is to support FPM in promoting innovation in medicine development and attracting new talent. Secondly is for actively connecting the physicians in my group both in the UK and globally with the opportunity to join a hub of pharmaceutical medicine excellence, where they can learn more from experts and peers.
Dr Stuart Dollow FFPM
Working with FPM provides me with an opportunity to help the Faculty to be as effective as it can. The strength and depth of our networks provides a strong foundation for high quality policies and positions that we contribute to and in maintaining the relevance and independence of the Faculty. It additionally allows me to meet and discuss with colleagues in different branches of pharmaceutical medicine, who have diverse experiences and perspectives; enriching our contribution as well as informing my own views. I enjoy the variety in my portfolio of work as it gives me energy and interest in a wider range of topics.
Dr Felix Jackson FFPM
I volunteer with FPM because I want to support their work advancing the science and practice of pharmaceutical medicine, which is a global medical speciality that supports the development of new treatments for patients.
Dr Maria Kapi
I volunteer for FPM because I believe in the purpose and in the value of FPM’s work for the pharmaceutical industry and ultimately for the patients.
Dr David Montgomery FFPM
Volunteering with the Faculty of Pharmaceutical Medicine gives me the opportunity to contribute to the future of a profession I care deeply about. I particularly value the chance to help shape how we communicate the importance of pharmaceutical medicine and ensure policy keeps pace with innovation – always with patients at the forefront of our thinking.
Dr Zoya Panahloo FFPM
I am pleased to be a member of the FPM Rare Disease and Gene Therapy Expert Group that aims to provide a platform to foster open dialogue, education and collaboration with all relevant stakeholders in rare diseases and Gene Therapy community. These remain challenging times, however it is only through open and transparent dialogue between industry, researchers, academics, regulators and patients that we can ensure that the patient perspective becomes an integral part of how medicines are developed and delivered to patients.
